SANTA CLARA, Calif., Jan. 18, 2018 /PRNewswire/ -- Frost & Sullivan's new analysis, Global Healthcare Industry Outlook, 2018
To access more information on this analysis, please visit: http://frost.ly/24j
Key predictions for 2018 growth opportunities in the global healthcare market include;
"Even though 2017 was a year full of spectacular advancements in healthcare, 2018 will be the year of digital health technologies such as artificial intelligence (AI), Internet of Medical Things (IoMT), big data analytics, and robotics," said Frost & Sullivan Transformational Health industry analyst Kamaljit Behera. "Non-healthcare companies will continue to collaborate with healthcare industry players to transform these technologies into actionable applications that will drive growth opportunities across the globe."
Global Healthcare Industry Outlook, 2018 is part of Frost & Sullivan's Transformational Health Growth Partnership Program.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
Global Healthcare Industry Outlook, 2018K227_54
Contact:Mariana FernandezCorporate Communications North AmericaP. (210) 348 1012E. email@example.com://ww2.frost.com Twitter: @FS_Healthcare LinkedIn: Transform Health
View original content:http://www.prnewswire.com/news-releases/frost--sullivans-2018-predictions-global-healthcare-market-will-skyrocket-to-nearly-2-trillion-in-2018-300584562.html
SOURCE Frost & Sullivan
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All